Lily Wong

Lily Wong is a seasoned scientist with extensive experience in the biotechnology field, currently serving as a Senior Scientist at Allogene Therapeutics since May 2018. In this role, Lily contributes to the development of allogeneic CAR-T analytical methods and implements cell-based assays to analyze cytokine secretion. Prior to Allogene Therapeutics, Lily worked at Pfizer, where Lily focused on developing and optimizing CAR-T analytical methods, as well as at Ology Bioservices, Inc., where Lily developed immunoassays for botulinum neurotoxin treatment. Lily has also held positions at XOMA Corporation, Facet Biotech, Novartis, and Pfizer, accumulating expertise in method development, validation, and GLP compliance across multiple therapeutic areas. Lily holds a Bachelor of Arts degree in Molecular Cell and Biology from the University of California, Berkeley.